Nicotinamide Riboside Benefits: 2026 Evidence Guide

Last updated: October 22, 2026 · Published by Eternal Elixir

Edited by Elaine Fletcher, Researcher

The best-supported nicotinamide riboside benefits are narrower than most supplement copy suggests. In controlled human trials, nicotinamide riboside (NR) reliably raises NAD+ and its related metabolites in blood and muscle, and it has been given at 1,000 mg a day for a full year with fewer serious adverse events than placebo. Trials that looked for bigger payoffs, such as stronger muscles in older adults or better outcomes in early Parkinson disease, mostly came back null. This guide sorts what NR has been shown to do from what is still a hypothesis, and turns every trial dose into 500 mg capsules and dollars per day.

If you already know you want NR and are comparing products, our nicotinamide riboside supplement comparison covers labels and price per dose. This page is for the earlier question: what does NR actually do?

Nicotinamide riboside benefits: what the human trials measured

Nicotinamide riboside is a form of vitamin B3. Your cells use it to make nicotinamide adenine dinucleotide (NAD+), a coenzyme that sits at the center of energy metabolism and cell signaling. NAD+ levels fall with age in animal studies, which is why NR became a longevity supplement in the first place.

The human research is consistent on one point. NR gets absorbed and it moves NAD+ numbers. Beyond that, the picture depends on which outcome you check.

Keep the scale in mind too. Most of the trials below were small and ran for weeks rather than years, and two of them were sponsored by an NR ingredient supplier, which the papers disclose.

NR raises NAD+ in a dose-dependent way

The first human pharmacokinetic study gave single doses of 100, 300 and 1,000 mg and found dose-dependent increases in the blood NAD+ metabolome. In one volunteer, blood NAD+ rose as much as 2.7-fold after a single dose (Trammell et al., Nature Communications, 2016).

A longer trial in overweight but otherwise healthy adults ran for 8 weeks. Whole-blood NAD+ rose 22%, 51% and 142% at 100, 300 and 1,000 mg a day, the rise appeared within 2 weeks, and it held for the rest of the study (Conze et al., Scientific Reports, 2019).

It reaches muscle in older men

In a crossover trial, 12 older men took 1 g of NR a day for 21 days. NR raised the NAD+ metabolome inside skeletal muscle and lowered circulating inflammatory cytokines, but it did not change mitochondrial bioenergetics (Elhassan et al., Cell Reports, 2019).

So the compound arrives where people hope it will. What it then changes in daily function is a separate question.

Tolerability has been good

Thirty adults aged 55 to 79 took 500 mg twice daily for 6 weeks in a placebo-controlled crossover trial. NR was well tolerated, no serious adverse events occurred, and the side effects reported were mild, including nausea.

The authors flagged blood pressure and arterial stiffness as outcomes worth testing in larger trials, which is a research lead and not a result (Martens et al., Nature Communications, 2018). The 8-week trial above reported no flushing and no difference in adverse events between NR and placebo.

How NR turns into NAD+

NR enters the NAD+ salvage pathway, the recycling route your cells already use to rebuild NAD+ from vitamin B3 fragments. That is why researchers call NR an NAD+ precursor. You take the building block, and your cells assemble the coenzyme.

On a label, NR usually appears as nicotinamide riboside chloride, the salt form used in the 8-week dose trial above. Eternal Elixir’s capsule declares 500 mg of β-nicotinamide riboside chloride per capsule, with rice flour as the only filler and a cellulose shell. When you compare products, check that the milligram figure refers to NR chloride itself and not to a proprietary blend.

Two practical points follow. First, blood NAD+ is a marker of exposure. It tells you the supplement is being absorbed and processed, and it does not by itself tell you anything changed in how you feel or perform.

Second, NR is one of several precursors. If you are deciding between NR and NMN, our NMN vs nicotinamide riboside comparison walks through the head-to-head data and cost.

Nicotinamide riboside benefits scorecard: measured vs. still unproven

Here is the evidence sorted by what was actually measured in people. Animal results are left out on purpose, because they are where most of the bolder marketing claims come from.

The muscle row comes from a 2025 systematic review and meta-analysis of randomized trials of NR and NMN in adults with a mean age over 60. Its authors concluded that current evidence does not support either precursor for preserving muscle mass and function (Prokopidis et al., Journal of Cachexia, Sarcopenia and Muscle, 2025).

The last row comes from a 2026 systematic review of 113 studies, including 33 human intervention studies. It found clear biochemical activity and good tolerability in people, with functional and healthspan outcomes that were “often null or endpoint-specific” (Gallagher and Emmanuel, Ageing Research Reviews, 2026).

None of this makes NR useless. It means the honest promise of NR is about supporting NAD+ levels, which is what the trials keep confirming, and that larger claims still need larger trials. The same evidence standard applies across the category, as our NAD+ supplement guide shows for the other precursors.

The 2026 NOPARK trial and what it means if you are healthy

On October 8, 2026, JAMA published NOPARK, a year-long NR trial. It randomized 410 people with Parkinson disease diagnosed in the previous 2 years to 500 mg of NR twice daily or placebo for 52 weeks, at 11 centers in Norway. The question was whether NR could slow the disease.

It did not. Total symptom scores rose by 2.45 points on NR and fell by 0.27 points on placebo, a difference of 2.72 points that favored placebo.

Non-motor symptoms also worsened more with NR. Serious adverse events were less common in the NR group, at 8.3% vs. 14.1% on placebo (Brakedal et al., JAMA, 2026).

Three things are worth taking from it if you do not have Parkinson disease. One year at 1,000 mg a day is a long controlled exposure, and serious adverse events did not rise. Raising NAD+ did not translate into a better clinical outcome in that population, which is a useful check on the idea that more NAD+ is always better. And if you live with a neurological condition, NR belongs in a conversation with your neurologist before it goes in your cabinet.

Trial doses translated into 500 mg capsules

Eternal Elixir Nicotinamide Riboside 500mg lists one capsule as a serving, with 60 capsules per bottle at $59.99. That works out to $1.00 per capsule. The table maps each human study to that capsule.

The pattern is plain once it is laid out. Almost every human trial used 1,000 mg a day, while one 500 mg capsule sits between the 300 mg and 1,000 mg arms of the 8-week dose study, where blood NAD+ rose 51% and 142%. A month at the trial dose costs about $60, and a month at the label serving costs about $30.

How to give NR a fair trial

Because the measurable effect is a blood marker, how you feel day to day is a weak guide. A more useful approach is to pick one outcome you care about, such as energy through the afternoon or recovery after training, write down a baseline, and change nothing else for 8 weeks. That matches the length of the longer dose study.

If you are also weighing other longevity compounds, add them one at a time. For Ca-AKG, our Ca-AKG side effects guide covers the calcium it adds before you put it next to NR.

Starting at the Eternal Elixir label serving of one capsule keeps the cost at $1.00 a day and sits inside the dose range that has been tested. Two capsules a day matches the dose used in most of the trials above, which is the figure that matters if you want to mirror the research. Follow the physical label for directions, and take NR at the same time each day so your notes compare like with like.

Talk to your doctor first if you are pregnant or breastfeeding, take prescription medication, or manage a chronic condition. NR trials have mostly enrolled healthy adults, and that is the group the safety data describes.

Nicotinamide riboside benefits: frequently asked questions

How long can you take nicotinamide riboside?

The longest controlled trial gave 1,000 mg a day for 52 weeks, and serious adverse events were less common on NR than on placebo. Shorter trials of 6 to 8 weeks also reported mild side effects only. We found no controlled trial longer than one year.

What not to take with nicotinamide riboside?

Human NR trials have not produced an established list of drug interactions, so ask a pharmacist if you take prescription medication. Avoid stacking several vitamin B3 products at once without advice. If you pair NR with resveratrol, our resveratrol interactions guide covers what to check on that side of the stack.

What happens if you take NR every day?

In an 8-week trial, daily NR raised whole-blood NAD+ within 2 weeks and the level stayed up for the rest of the study. Side effects reported across trials were mild, such as nausea. Whether that rise changes how you feel has not been shown consistently.

What is the difference between NAD+ and nicotinamide riboside?

NAD+ is the coenzyme your cells use for energy metabolism. Nicotinamide riboside is a vitamin B3 form that your cells convert into NAD+ through the salvage pathway. Taking NR is a way to supply the raw material, and the trials measure success by how much NAD+ goes up.

How long does it take to see the effects of NR?

Blood NAD+ rises after a single dose in pharmacokinetic studies, and daily use reached a steady higher level within 2 weeks. Any change you notice in energy or recovery is less predictable, so give it at least 8 weeks with a written baseline before you judge it.

References

• Trammell SA, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communications. 2016. PMID 27721479
• Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. 2018. PMID 29599478
• Conze D, et al. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Scientific Reports. 2019. PMID 31278280
• Elhassan YS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Reports. 2019. PMID 31412242
• Prokopidis K, et al. The effect of nicotinamide mononucleotide and riboside on skeletal muscle mass and function: a systematic review and meta-analysis. Journal of Cachexia, Sarcopenia and Muscle. 2025. PMID 40275690
• Gallagher C, Emmanuel OO. NAD+ supplementation for anti-aging and wellness: a PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Research Reviews. 2026. PMID 41655607
• Brakedal B, et al. Nicotinamide riboside for patients with early-stage Parkinson disease: the NOPARK randomized clinical trial. JAMA. 2026. PMID 42848371